Narrows Institute for Biomedical Research Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT04169100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Narrows Institute for Biomedical Research

Active Ingredients

Drugs in Phase 4 Trials (2)

prednisone (meticorten) (1 trial)

secukinumab (cosentyx) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Connective Tissue Diseases (Phase 4)

Long QT Syndrome (Phase 4)

Psoriasis (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2